Needham Maintains Buy on Boston Scientific, Raises Price Target to $86
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $82 to $86.
July 25, 2024 | 10:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has maintained a Buy rating on Boston Scientific and increased the price target from $82 to $86.
The Buy rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100